| Name | Title | Contact Details |
|---|
Vericred, Inc. is a healthcare data services company, operating at the intersection of health insurance and technology. Vericred serves companies who are transforming today`s healthcare experience, from care management to finding the right insurance plan. Its datasets are the foundation on which the healthcare industry builds innovative solutions. Vericred`s health insurance data platform, which is comprised of plan design and rate data, provider-network data and formulary data, offers a solution to an industry plagued by highly fragmented, rapidly changing data that currently exists in non-standard and non-structured formats.
obé is a premium fitness network and community that gets you results AND brings the fun. With 22 live classes per day and 5,000+ on-demand workouts available 24/7—all taught by the best instructors in NYC—our motto is: get fit, not bored. From HIIT to Pilates to Dance, Sculpt, Strength, Yoga, Pre/Postnatal, Cardio Boxing, and more, obé classes are designed to meet you wherever you are in your fitness journey.
Home Health Care Management (HHCM) is the parent and management company for our family of home health care providers - Berks Visiting Nurse Association, Visiting Nurse Association of Pottstown and Vicinity, Greater Lehigh Valley Visiting Nurse Association, and Advantage Home Care.
RSi FocalSearch is a Englewd Clfs, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.